- Home
- Publications
- Publication Search
- Publication Details
Title
New Targets in Heart Failure Drug Therapy
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-05
DOI
10.3389/fcvm.2021.665797
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The vasculature: a therapeutic target in heart failure?
- (2021) Guillermo Luxán et al. CARDIOVASCULAR RESEARCH
- Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo‐controlled trial
- (2020) Valentina Carubelli et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of Elamipretide on Left Ventricular Function in Patients with Heart Failure with Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial
- (2020) Javed Butler et al. JOURNAL OF CARDIAC FAILURE
- Empagliflozin Protects Cardiac Mitochondrial Fatty Acid Metabolism in a Mouse Model of Diet-Induced Lipid Overload
- (2020) Marina Makrecka-Kuka et al. CARDIOVASCULAR DRUGS AND THERAPY
- Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
- (2020) Detmar Kolijn et al. CARDIOVASCULAR RESEARCH
- Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4
- (2020) Javier Díez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
- (2020) Paul W. Armstrong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure
- (2020) Michele Ciccarelli et al. ESC Heart Failure
- Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities
- (2020) Giovanni Quarta et al. EUROPEAN JOURNAL OF HEART FAILURE
- SPEG: a key regulator of cardiac calcium homeostasis
- (2020) Hannah Campbell et al. CARDIOVASCULAR RESEARCH
- Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin V1a/V2 receptor antagonist in experimental heart failure
- (2020) Thomas Mondritzki et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial
- (2020) Steven R. Goldsmith et al. JOURNAL OF CARDIAC FAILURE
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coronary Microvascular Dysfunction
- (2020) Federico Vancheri et al. Journal of Clinical Medicine
- Signalling pathways linking cysteine cathepsins to adverse cardiac remodelling
- (2020) Dylan O'Toole et al. CELLULAR SIGNALLING
- GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction
- (2020) Lili Zhang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
- (2020) John R. Teerlink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?
- (2019) Carlos G. Santos-Gallego et al. CARDIOVASCULAR DRUGS AND THERAPY
- Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure
- (2019) G. Michael Felker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction
- (2019) Sanjiv J. Shah et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vascular Protection and Decongestion Without Renin–Angiotensin–Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist
- (2019) Peter Kolkhof et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
- (2019) Jesper Jensen et al. Trials
- The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking
- (2019) Arantxa González et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double‐blind, placebo‐controlled trial
- (2019) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure
- (2019) Michele Correale et al. European Journal of Internal Medicine
- Targeting pathological leak of ryanodine receptors: preclinical progress and the potential impact on treatments for cardiac arrhythmias and heart failure
- (2019) Patrick Connell et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
- (2018) Stephen D. Wiviott et al. AMERICAN HEART JOURNAL
- Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated C-Reactive Protein
- (2018) Cory Trankle et al. AMERICAN JOURNAL OF CARDIOLOGY
- Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling
- (2018) Louis J. Dell’Italia et al. CIRCULATION RESEARCH
- Redefining biomarkers in heart failure
- (2018) Michele Correale et al. HEART FAILURE REVIEWS
- Inhibition of ERK-Drp1 signaling and mitochondria fragmentation alleviates IGF-IIR-induced mitochondria dysfunction during heart failure
- (2018) Chih-Yang Huang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3
- (2018) Rebecca M. Parodi-Rullán et al. Frontiers in Physiology
- Amelioration of mitochondrial dysfunction in heart failure through S-sulfhydration of Ca2+/calmodulin-dependent protein kinase II
- (2018) Dan Wu et al. Redox Biology
- Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling
- (2018) Jiali Nie et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction
- (2017) Cristina Tita et al. EUROPEAN JOURNAL OF HEART FAILURE
- Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study
- (2017) Gerasimos Filippatos et al. EUROPEAN JOURNAL OF HEART FAILURE
- GRK2 as a therapeutic target for heart failure
- (2017) Alessandro Cannavo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Omecamtiv Mecarbil Enhances the Duty Ratio of Human β-Cardiac Myosin Resulting in Increased Calcium Sensitivity and Slowed Force Development in Cardiac Muscle
- (2017) Anja M. Swenson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of NOD1 in Heart Failure Progression via Regulation of Ca 2+ Handling
- (2017) Almudena Val-Blasco et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Knowledge About Old Drugs: The Anti-Inflammatory Properties of Cardiac Glycosides
- (2017) Robert Fürst et al. PLANTA MEDICA
- Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball
- (2017) Carsten Tschöpe et al. Current Cardiology Reports
- Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure
- (2017) Adam Riba et al. PLoS One
- Activation of common signaling pathways during remodeling of the heart and the bladder
- (2016) Ivonne Koeck et al. BIOCHEMICAL PHARMACOLOGY
- The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling
- (2016) Elizabeth A. Vecchio et al. BIOCHEMICAL PHARMACOLOGY
- miR-185 inhibits endoplasmic reticulum stress-induced apoptosis by targeting Na+/H+exchanger-1 in the heart
- (2016) Jin Ock Kim et al. BMB Reports
- Improvement of cardiovascular remodelling by chymase inhibitor
- (2016) Shinji Takai et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Interaction of Galectin-3 Concentrations with the Treatment Effects of -Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF
- (2016) S. S.-v. Wijk et al. CLINICAL CHEMISTRY
- Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis
- (2016) Vojtech Melenovsky et al. EUROPEAN JOURNAL OF HEART FAILURE
- LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice
- (2016) Yasunori Suematsu et al. EUROPEAN JOURNAL OF HEART FAILURE
- MicroRNA and receptor mediated signaling pathways as potential therapeutic targets in heart failure
- (2016) Antonino Tuttolomondo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure
- (2016) Adriaan Alexander Voors et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Role of protein phosphatase inhibitor-1 in cardiac beta adrenergic pathway
- (2016) Silvio Weber et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure
- (2016) John R. Teerlink et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial
- (2016) John R Teerlink et al. LANCET
- Mitochondrial function as a therapeutic target in heart failure
- (2016) David A. Brown et al. Nature Reviews Cardiology
- Oleuropein attenuates the progression of heart failure in rats by antioxidant and antiinflammatory effects
- (2016) Zeinab Janahmadi et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure
- (2016) Ilonka Rohm et al. Journal of Immunology Research
- Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
- (2016) Constantijn Franssen et al. JACC-Heart Failure
- The proposed new classification of coronary microcirculation as the predictor of the heart failure progression in idiopathic dilated cardiomyopathy
- (2015) Katarzyna E. Gil et al. CARDIOVASCULAR PATHOLOGY
- Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials
- (2015) Kwadwo Osei Bonsu et al. Cardiovascular Therapeutics
- FasL expression in cardiomyocytes activates the ERK1/2 pathway, leading to dilated cardiomyopathy and advanced heart failure
- (2015) A.-C. Huby et al. CLINICAL SCIENCE
- Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF
- (2015) Matthew J. Feinstein et al. EUROPEAN JOURNAL OF HEART FAILURE
- Prognostic impact of metabolic syndrome in patients with chronic heart failure: Data from GISSI-HF trial
- (2015) Pasquale Perrone-Filardi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction
- (2015) Mihai Gheorghiade et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Heart failure: Novel therapeutic approaches
- (2015) C Patel et al. Journal of Postgraduate Medicine
- Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart
- (2015) Jianru Shi et al. LIFE SCIENCES
- Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage
- (2015) Erik B. Schelbert et al. Journal of the American Heart Association
- Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)
- (2014) Bernard Zinman et al. Cardiovascular Diabetology
- Serendipity and the Discovery of Novel Compounds That Restore Mitochondrial Plasticity
- (2014) H H Szeto et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition
- (2013) Mara Ferrandi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting mitochondrial cardiolipin and the cytochromec/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis
- (2013) A V Birk et al. BRITISH JOURNAL OF PHARMACOLOGY
- Strategies and Opportunities for Drug Development in Heart Failure
- (2013) Javed Butler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
- (2012) Loek van Heerebeek et al. CIRCULATION
- Impaired Myocardial Perfusion Reserve in Patients With Fatty Liver Disease Assessed by Quantitative Myocardial Perfusion Magnetic Resonance Imaging
- (2012) Shiro Nakamori et al. CIRCULATION JOURNAL
- Coronary microvascular dysfunction in the clinical setting: from mystery to reality
- (2012) J. Herrmann et al. EUROPEAN HEART JOURNAL
- Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials
- (2012) Roberto Latini et al. EUROPEAN JOURNAL OF HEART FAILURE
- Soluble guanylate cyclase: a potential therapeutic target for heart failure
- (2012) Mihai Gheorghiade et al. HEART FAILURE REVIEWS
- Collagen Cross-Linking But Not Collagen Amount Associates With Elevated Filling Pressures in Hypertensive Patients With Stage C Heart Failure
- (2012) Begoña López et al. HYPERTENSION
- Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure
- (2012) Zhehao Dai et al. Journal of Cardiology
- Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: Comparison with cyclosporine A
- (2011) Anna Onishi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention—An in vivo perspective
- (2011) Susan Currie et al. PHARMACOLOGY & THERAPEUTICS
- Chymase-Dependent Generation of Angiotensin II from Angiotensin-(1-12) in Human Atrial Tissue
- (2011) Sarfaraz Ahmad et al. PLoS One
- Changes in the Myocardial Interstitium and Contribution to the Progression of Heart Failure
- (2011) Shaina R. Eckhouse et al. Heart Failure Clinics
- Improvement of Cardiac Function by a Cardiac Myosin Activator in Conscious Dogs With Systolic Heart Failure
- (2010) You-Tang Shen et al. Circulation-Heart Failure
- Titin-based mechanical signalling in normal and failing myocardium
- (2009) Martina Krüger et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Chronic inhibition of the Na+/H+- exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling
- (2008) A Baartscheer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Gender-specific hypertension and responsiveness to nitric oxide in sGCα1 knockout mice
- (2008) Emmanuel S. Buys et al. CARDIOVASCULAR RESEARCH
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now